Patents by Inventor Edwin M. Meyer

Edwin M. Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human disease modeling using somatic gene transfer
    Publication number: 20040205833
    Abstract: The invention provides a system for modeling neurodegenerative and other diseases through somatic gene transfer. In addition, methods of multiple gene transfer, disease analysis and drug testing are provided for.
    Type: Application
    Filed: June 1, 2004
    Publication date: October 14, 2004
    Inventors: Ronald Klein, Edwin M Meyer, Nicholas Muzyczka, Michael A King, Craig A Meyers
  • Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
    Patent number: 6630491
    Abstract: Method of using anabaseine, DMAB-anabaseine, and anabaseine for stimulating brain cholinergic transmission and a method of making anabaseine.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 7, 2003
    Assignee: University of Florida
    Inventors: John A Zoltewicz, William R. Kem, Edwin M. Meyer
  • Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
    Patent number: 5741802
    Abstract: The invention concerns novel anabaseine-related compounds that are useful in treating certain degenerative neural diseases such as Alzheimer's and Parkinson's which apparently involve decreased function of cerebral cortical nicotinic receptors. The compounds showed activity in both in vitro and in active and passive active avoidance studies in animal models. An exemplary active compound is a 3-substituted 2,4-dimethoxy-benzylidene anabaseine.
    Type: Grant
    Filed: January 5, 1996
    Date of Patent: April 21, 1998
    Assignee: University of Florida
    Inventors: William R. Kem, John A. Zoltewicz, Edwin M. Meyer, Katalin Prokai-Tatrai
  • Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
    Patent number: 5516785
    Abstract: Method of using anabaseine, and DMAB-anabaseine for stimulating brain cholinergic transmission and a method of making anabaseine.
    Type: Grant
    Filed: October 21, 1993
    Date of Patent: May 14, 1996
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: John A. Zoltewicz, William R. Kem, Edwin M. Meyer